首页> 外文期刊>The International journal of pharmacy practice >It's for your benefit: Exploring patients' opinions about the inclusion of textual and numerical benefit information in medicine leaflets
【24h】

It's for your benefit: Exploring patients' opinions about the inclusion of textual and numerical benefit information in medicine leaflets

机译:这对您有好处:探索患者对药物传单中包含文字和数字益处信息的看法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives To explore consumers' beliefs and preferences for benefit information in medicine leaflets and examine their understanding and reaction to treatment benefits. Methods Forty-five participants were recruited to eight focus groups, run concurrently in Australia (23 participants in four groups) and the UK (22 participants in four groups). Participants were provided with amended leaflets based on the medicine clopidogrel, containing textual and numerical benefit information presented using numbers needed to treat (NNT). A topic guide which explored use of leaflets, preferences and opinions was used to direct discussion. Focus group discussions were recorded, transcribed verbatim and content analysed using adapted cross-case study analysis. Key findings The consensus was that the inclusion of benefit information was a positive factor. Many participants felt that textual benefit information offered an incentive to take a medicine, although some Australian participants had concerns that included benefit information could create anxiety. The presentation of numerical benefit information provoked strong feelings of disbelief and shock. Participants were surprised that so few people would benefit. Some participants struggled to understand and interpret the NNT and others found it difficult to comprehend the magnitude of the benefit information, instead operating on initial and often crude assumptions of what the data meant. In both countries the provision of numerical benefit information appeared to shake participants' faith in drug treatments. Participants were concerned about how this might affect the 'less-informed' patient. However, in the UK, participants stated that their adherence to treatment was also reinforced by their doctor's advice. Conclusions Participants wanted to receive information about the benefits of their medicines. However, they may misinterpret the numerical information provided.
机译:目的探索消费者对药品传单中有益信息的信念和偏好,并检查他们对治疗益处的理解和反应。方法:将45名参与者分为8个焦点小组,分别在澳大利亚(4个小组中的23名参与者)和英国(4个小组中的22名参与者)同时进行。为参加者提供了基于氯吡格雷药物的修订传单,其中包含使用治疗所需数字(NNT)呈现的文字和数字福利信息。主题指南探讨了传单,偏好和观点的使用,用于指导讨论。记录了焦点小组的讨论,记录了逐字记录,并使用跨案例研究分析对内容进行了分析。主要发现共识是,包括福利信息是一个积极因素。尽管一些澳大利亚参与者担心包含收益信息可能会引起焦虑,但许多参与者认为,文字收益信息为服用药物提供了动力。数字效益信息的呈现引起强烈的怀疑和震惊感。与会者惊讶的是,很少有人会受益。一些参与者难以理解和解释NNT,而另一些参与者则难以理解收益信息的大小,而是根据数据含义的初始且通常是粗略的假设进行操作。在这两个国家,提供数字效益信息似乎动摇了参与者对毒品治疗的信念。参与者担心这会如何影响“消息灵通”的患者。但是,在英国,参与者表示,医生的建议也加强了他们对治疗的依从性。结论参与者希望获得有关其药物益处的信息。但是,它们可能会误解所提供的数字信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号